Open AccessSAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
Author(s) -
Aneesh Ms
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-lb031
Subject(s) - empagliflozin , medicine , metformin , overweight , type 2 diabetes mellitus , diabetes mellitus , type 2 diabetes , population , glycated haemoglobin , obesity , endocrinology , environmental health